Agios Pharmaceuticals (AGIO) Financials: Revenue & Earnings
AGIO$38.27+0.24 +0.63%
$2.28B
Market Cap
-5.36
P/E
28.86
Forward P/E
54
Score
Agios Pharmaceuticals (AGIO) Financials: Revenue & Earnings
AGIO price $38.27 +0.24 +0.63%
- Ticker
- AGIO
- Price
- $38.27
- Change
- +0.24 +0.63%
- Market cap ?
- $2.28B
- P/E ?
- -5.36
- Forward P/E ?
- 28.86
- Dividend yield ?
- 0.00%
- Beta ?
- 0.63
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
- Value
- 46
- Quality
- 47
- Growth
- 69
Stocklytics score rationale: value 46, quality 47, growth 69.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 69892000 | 43011000 | 94387000 | 117912000 | 0 | 0 | 14240000 | 26823000 | 36498000 | 54028000 |
Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is…
Fair value
AGIO fair value $28.39. Price $38.27. Price is 35% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 5.13M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 59.70M. Net debt -48.92M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -1.25 | — | 51.55M |
| 2026-07-30 | -1.69 | -1.65 | 44.74M | 26.40M |
| 2026-04-29 | -1.69 | -1.81 | 20.75M | 13.30M |
| 2026-02-12 | -1.85 | -1.97 | 19.97M | 12.09M |
| 2025-10-30 | -1.78 | -1.93 | 12.88M | 11.70M |
| 2025-07-31 | -1.93 | -1.74 | 12.46M | 10.28M |
| 2025-05-01 | -1.55 | -1.80 | 8.73M | 9.99M |
| 2025-02-13 | -1.74 | -1.69 | 10.73M | 9.35M |
| 2024-10-31 | 16.22 | 15.22 | 9.00M | 9.44M |
| 2024-08-01 | -1.69 | -1.58 | 8.62M | 9.31M |
| 2024-05-02 | -1.45 | -1.64 | 8.19M | 9.75M |
| 2024-02-15 | -1.72 | -1.64 | 7.10M | 7.92M |
| 2023-11-02 | -1.64 | -1.69 | 7.40M | 7.53M |
| 2023-08-03 | -1.51 | -1.60 | 6.71M | 6.46M |
| 2023-05-04 | -1.47 | -1.72 | 5.61M | 5.23M |
| 2023-02-23 | 0.67 | -1.59 | 4.31M | 4.54M |
| 2022-11-03 | -1.49 | -1.75 | 3.52M | 5.27M |
| 2022-08-04 | -1.68 | -1.78 | 5.58M | 2.91M |
| 2022-05-05 | -1.74 | -1.85 | 832.00K | 864.18K |
| 2022-02-24 | -1.81 | -1.71 | 41 | 2.94M |
| 2021-11-03 | -1.48 | -1.61 | — | 2.60M |
| 2021-07-29 | -1.36 | -1.39 | 37.35M | — |
| 2021-04-29 | -1.31 | -1.23 | 41.41M | 43.53M |
| 2021-02-25 | -1.41 | -1.41 | 44.05M | 40.17M |
| 2020-11-05 | -1.43 | -1.40 | 34.71M | 33.49M |
| 2020-07-30 | -1.31 | -1.42 | 37.35M | 39.06M |
| 2020-04-30 | -0.59 | -1.70 | 87.10M | 246.53M |
| 2020-02-13 | -1.60 | -1.78 | 35.44M | 38.10M |
| 2019-10-31 | -1.81 | -1.85 | 26.02M | 25.88M |
| 2019-08-01 | -1.87 | -1.73 | 26.22M | 23.84M |
| 2019-05-02 | -1.59 | -1.74 | 30.23M | 33.27M |
| 2019-02-14 | -1.58 | -1.65 | 30.01M | 31.72M |
| 2018-11-01 | -1.63 | -1.69 | 15.20M | 15.10M |
| 2018-08-02 | -1.19 | -1.62 | 40.41M | 52.64M |
| 2018-05-04 | -1.63 | -1.60 | 8.76M | 8.76M |
| 2018-02-14 | -1.81 | -1.65 | 9.80M | 8.99M |
| 2017-11-01 | -1.59 | -1.74 | 11.36M | 12.79M |
| 2017-08-08 | -1.78 | -1.52 | 11.35M | 9.94M |
| 2017-05-04 | -1.56 | -1.79 | 10.51M | 11.52M |
| 2017-02-16 | -1.34 | -1.55 | 22.65M | 25.52M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-22 | Gheuens Sarah | Buy | 500 | $25.01 | 12.51K |
| 2026-10-22 | Gheuens Sarah | Sell | 500 | $37.52 | 18.76K |
| 2026-10-22 | Gheuens Sarah | Sell | 500 | $25.01 | 12.51K |
| 2026-10-21 | Gheuens Sarah | Buy | 1.49K | $25.01 | 37.24K |
| 2026-10-21 | Gheuens Sarah | Sell | 1.49K | $37.53 | 55.88K |
| 2026-10-21 | Gheuens Sarah | Sell | 1.49K | $25.01 | 37.24K |
| 2026-08-04 | Gheuens Sarah | Sell | 30.00K | $30.48 | 914.40K |
| 2026-07-08 | Backstrom Jay T. | Sell | 1.45K | — | — |
| 2026-07-08 | Backstrom Jay T. | Buy | 1.45K | — | — |
| 2026-07-01 | Gheuens Sarah | Buy | 8.38K | — | — |
| 2026-07-01 | Gheuens Sarah | Sell | 4.01K | $37.56 | 150.50K |
| 2026-07-01 | Gheuens Sarah | Sell | 8.38K | — | — |
| 2026-06-18 | Ballal Rahul D. | Buy | 2.82K | — | — |
| 2026-06-18 | Ballal Rahul D. | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Ballal Rahul D. | Buy | 2.93K | — | — |
| 2026-06-18 | Ballal Rahul D. | Sell | 2.82K | — | — |
| 2026-06-18 | CAPELLO JEFFREY D | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | CAPELLO JEFFREY D | Buy | 2.82K | — | — |
| 2026-06-18 | CAPELLO JEFFREY D | Buy | 2.93K | — | — |
| 2026-06-18 | CAPELLO JEFFREY D | Sell | 2.82K | — | — |
| 2026-06-18 | Foster-Cheek Kaye I | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Foster-Cheek Kaye I | Buy | 2.82K | — | — |
| 2026-06-18 | Foster-Cheek Kaye I | Buy | 2.93K | — | — |
| 2026-06-18 | Foster-Cheek Kaye I | Sell | 2.82K | — | — |
| 2026-06-18 | FOUSE JACQUALYN A | Buy | 2.82K | — | — |
| 2026-06-18 | FOUSE JACQUALYN A | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | FOUSE JACQUALYN A | Buy | 2.93K | — | — |
| 2026-06-18 | FOUSE JACQUALYN A | Sell | 2.82K | — | — |
| 2026-06-18 | Ho Maykin | Buy | 2.82K | — | — |
| 2026-06-18 | Ho Maykin | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Ho Maykin | Buy | 2.93K | — | — |
| 2026-06-18 | Ho Maykin | Sell | 2.82K | — | — |
| 2026-06-18 | Owen Adams Catherine | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Owen Adams Catherine | Buy | 2.82K | — | — |
| 2026-06-18 | Owen Adams Catherine | Buy | 2.93K | — | — |
| 2026-06-18 | Owen Adams Catherine | Sell | 2.82K | — | — |
| 2026-06-18 | Scadden David | Buy | 2.82K | — | — |
| 2026-06-18 | Scadden David | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Scadden David | Buy | 2.93K | — | — |
| 2026-06-18 | Scadden David | Sell | 2.82K | — | — |
| 2026-06-18 | Smith Cynthia | Buy | 2.82K | — | — |
| 2026-06-18 | Smith Cynthia | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Smith Cynthia | Buy | 2.93K | — | — |
| 2026-06-18 | Smith Cynthia | Sell | 2.82K | — | — |
| 2026-06-18 | Viswanadhan Krishnan | Sell | 3.00K | — | — |
| 2026-06-18 | Viswanadhan Krishnan | Buy | 3.00K | — | — |
| 2026-06-18 | Goff Brian | Sell | 39.00K | — | — |
| 2026-06-18 | Goff Brian | Buy | 39.00K | — | — |
| 2026-06-18 | Burns James William | Sell | 3.00K | — | — |
| 2026-06-18 | Burns James William | Buy | 3.00K | — | — |
| 2026-06-18 | Gheuens Sarah | Sell | 3.00K | — | — |
| 2026-06-18 | Gheuens Sarah | Buy | 3.00K | — | — |
| 2026-06-18 | Jones Cecilia | Sell | 3.00K | — | — |
| 2026-06-18 | Jones Cecilia | Buy | 3.00K | — | — |
| 2026-06-18 | Milanova Tsveta | Sell | 3.00K | — | — |
| 2026-06-18 | Milanova Tsveta | Buy | 3.00K | — | — |
| 2026-06-18 | Backstrom Jay T. | Buy | 14.95K | $34.16 | 510.69K |
| 2026-06-18 | Backstrom Jay T. | Buy | 2.93K | — | — |
| 2026-06-13 | Owen Adams Catherine | Buy | 1.98K | — | — |
| 2026-06-13 | Owen Adams Catherine | Sell | 1.98K | — | — |
| 2026-06-13 | CAPELLO JEFFREY D | Buy | 1.98K | — | — |
| 2026-06-13 | CAPELLO JEFFREY D | Sell | 1.98K | — | — |
| 2026-04-02 | Burns James William | Buy | 8.50K | — | — |
| 2026-04-02 | Burns James William | Sell | 3.28K | $34.71 | 113.85K |
| 2026-04-02 | Burns James William | Sell | 8.50K | — | — |
| 2026-04-02 | Gheuens Sarah | Buy | 8.50K | — | — |
| 2026-04-02 | Gheuens Sarah | Sell | 2.94K | $34.71 | 102.05K |
| 2026-04-02 | Gheuens Sarah | Sell | 8.50K | — | — |
| 2026-04-02 | Jones Cecilia | Buy | 8.50K | — | — |
| 2026-04-02 | Jones Cecilia | Sell | 3.14K | $34.71 | 109.02K |
| 2026-04-02 | Jones Cecilia | Sell | 8.50K | — | — |
| 2026-04-02 | Milanova Tsveta | Buy | 8.50K | — | — |
| 2026-04-02 | Milanova Tsveta | Sell | 3.26K | $34.71 | 113.22K |
| 2026-04-02 | Milanova Tsveta | Sell | 8.50K | — | — |
| 2026-04-02 | Viswanadhan Krishnan | Buy | 8.10K | — | — |
| 2026-04-02 | Viswanadhan Krishnan | Sell | 2.96K | $34.71 | 102.71K |
| 2026-04-02 | Viswanadhan Krishnan | Sell | 8.10K | — | — |
| 2026-04-02 | Goff Brian | Buy | 13.50K | — | — |
| 2026-04-02 | Goff Brian | Buy | 25.53K | — | — |
| 2026-04-02 | Goff Brian | Sell | 6.60K | $34.71 | 228.95K |
| 2026-04-02 | Goff Brian | Sell | 12.47K | $34.71 | 432.90K |
| 2026-04-02 | Goff Brian | Sell | 13.50K | — | — |
| 2026-04-02 | Goff Brian | Sell | 25.53K | — | — |
| 2026-03-05 | Viswanadhan Krishnan | Sell | 8.10K | — | — |
| 2026-03-05 | Viswanadhan Krishnan | Buy | 8.10K | — | — |
| 2026-03-05 | Viswanadhan Krishnan | Sell | 2.96K | $27.80 | 82.26K |
| 2026-03-03 | Washburn Theodore James Jr. | Sell | 5.27K | $28.88 | 152.26K |
| 2026-03-02 | Goff Brian | Buy | 13.00K | — | — |
| 2026-03-02 | Goff Brian | Buy | 18.00K | — | — |
| 2026-03-02 | Goff Brian | Sell | 5.92K | $28.96 | 171.39K |
| 2026-03-02 | Goff Brian | Sell | 8.27K | $28.96 | 239.41K |
| 2026-03-02 | Goff Brian | Buy | 8.50K | — | — |
| 2026-03-02 | Goff Brian | Sell | 3.87K | $28.96 | 112.08K |
| 2026-03-02 | Goff Brian | Sell | 13.00K | — | — |
| 2026-03-02 | Goff Brian | Sell | 18.00K | — | — |
| 2026-03-02 | Goff Brian | Sell | 8.50K | — | — |
| 2026-03-02 | Burns James William | Buy | 3.92K | — | — |
| 2026-03-02 | Burns James William | Sell | 1.16K | $28.96 | 33.68K |
| 2026-03-02 | Burns James William | Buy | 4.00K | — | — |
| 2026-03-02 | Burns James William | Sell | 1.19K | $28.96 | 34.38K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 252, holders +3 vs prior quarter. Ownership 113.20%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 6.46M | 701.04K | +12.18% | 239.58M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.92M | 233.40K | +4.11% | 219.59M |
| STATE STREET CORP | 3.53M | 168.75K | +5.02% | 131.14M |
| LYNX1 CAPITAL MANAGEMENT LP | 3.41M | 797.37K | +30.53% | 126.51M |
| D. E. SHAW & CO., INC. | 3.11M | 425.84K | +15.88% | 115.30M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.90M | 287.16K | +11.00% | 107.55M |
| ARMISTICE CAPITAL, LLC | 2.81M | 94.00K | +3.46% | 104.28M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.68M | 49.53K | +1.88% | 99.52M |
| ARMISTICE CAPITAL, LLC | 2.40M | -316.00K | -11.63% | 89.06M |
| ERSTE ASSET MANAGEMENT GMBH | 2.15M | -550.00K | -20.33% | 81.97M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.11M | 616.37K | +41.24% | 78.33M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.57M | 106.36K | +7.25% | 58.43M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.38M | 1.28M | +1355.62% | 51.05M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 1.29M | 1.15M | +815.64% | 47.80M |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.28M | -300.80K | -19.03% | 47.50M |
| DIMENSIONAL FUND ADVISORS LP | 1.25M | 97.12K | +8.43% | 46.35M |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.21M | -8.29K | -0.68% | 44.78M |
| GOLDMAN SACHS GROUP INC | 1.15M | 345.16K | +42.84% | 42.71M |
| UBS GROUP AG | 985.83K | 853.29K | +643.80% | 36.58M |
| MORGAN STANLEY | 963.26K | -4.27K | -0.44% | 35.75M |
| NUVEEN, LLC | 873.56K | 151.21K | +20.93% | 32.42M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 810.53K | 560.07K | +223.62% | 30.08M |
| FORESITE CAPITAL MANAGEMENT VI LLC | 785.00K | 260.00K | +49.52% | 29.13M |
| CITADEL ADVISORS LLC | 732.69K | 666.99K | +1015.20% | 27.19M |
| AQR CAPITAL MANAGEMENT LLC | 684.34K | 684.34K | New | 25.40M |
Earnings and financials
Agios Pharmaceuticals, Inc. (AGIO) trades at $38.27, with a market cap of $2.28B and a trailing P/E of -5.36. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 69892000 | 43011000 | 94387000 | 117912000 | 0 | 0 | 14240000 | 26823000 | 36498000 | 54028000 |
Insights · Dividends · Forecast · Financials · Learn